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Sex traffi cking may play a major role in spread of HIV 
across South Asia. We investigated co-infection with HIV 
and other sexually transmitted diseases among 246 sex-
traffi cked women and girls from Nepal. Those who were HIV 
positive were more likely than those who were HIV negative 
to be infected with syphilis and/or hepatitis B.
South Asia is currently home to >2.5 million HIV-infected persons, 95% of whom are from India (1). 
However, HIV seroprevalence in a subset of neighbor-
ing South Asian countries has rapidly increased in recent 
years, due in part to migration and human traffi cking 
from these countries into India (1–3). Female sex work-
ers, especially those who are victims of sex traffi cking to 
India, are increasingly recognized as a major factor in Ne-
pal’s growing HIV epidemic (2,4,5). HIV seroprevalence 
among female sex workers in Nepal rose 24-fold (from 
<1% to 17%) from 1992 through 2002 (6). Women and 
girls traffi cked for sexual exploitation from Nepal to India 
are considered particularly vulnerable to HIV infection 
because of their typically young age at traffi cking, limited 
ability to negotiate condom-protected sex, and experienc-
es of forced sex (4,7). Recent evidence documents high 
(38%) HIV seroprevalence among sex-traffi cked women 
and girls returning from India to Nepal (5).
Despite high rates of HIV infection among sex-traf-
fi cked victims (5,8) and substantial prevalence of sexually 
transmitted infections (STIs) among female sex workers in 
South Asia and elsewhere (9,10), little is known about STI 
prevalence and co-infection with HIV among sex-traffi cked 
women and girls. We therefore explored prevalence of 
syphilis and hepatitis B and co-infection with HIV among 
a sample of female sex-traffi cking victims in Nepal.
The Study
Data for this study were extracted from medical re-
cords of 395 women and girls examined at Maiti Nepal, a 
large nongovernment organization in Kathmandu, Nepal, 
which provides shelter and healthcare for sex-traffi cking 
victims repatriated to Nepal. Upon intake and pending ver-
bal consent, all sex-traffi cking victims at Maiti Nepal are 
routinely tested for HIV and STIs. We excluded records of 
149 because they lacked HIV test or accompanying syphi-
lis or hepatitis B test documentation. Study protocols were 
approved by the Harvard School of Public Health Human 
Subjects Committee.
Standard HIV antibody testing was performed by us-
ing HIV ELISA, rapid testing, or Western blot. Syphilis 
testing was performed by using a nontreponemal serologic 
test, the Venereal Disease Research Laboratory test; all 
samples tested had titers >1:8 dilution, which strongly sug-
gests true syphilis infection. (11) Serologic detection of the 
hepatitis B virus surface antigen was indicative of hepatitis 
B infection.
Age at time of HIV testing ranged from 13 to 40 years 
(median age 20 years), median age at the time of traffi ck-
ing was 17 years (range 7–32 years), and median duration 
of brothel servitude was 12 months (range <1 month–13 
years). A series of Fisher exact tests conducted to assess for 
potential biases in selection for diagnostic testing showed 
no differences in demographic or experiential variables (i.e., 
current age, age at traffi cking, duration in brothel), and Mc-
Nemar tests showed no relationship between likelihood of 
testing for syphilis or hepatitis B based on a positive HIV 
test result (all p>0.05). Because of the paired nature of the 
data, the McNemar test involving a continuity correction 
was used to assess associations between 1) HIV status and 
co-infection with syphilis, 2) HIV status and co-infection 
with hepatitis B, and 3) HIV status and co-infection with 
hepatitis B or syphilis.
Of the 246 women and girls in the study, 74 (30.1%, 
≈1 in 3) had positive HIV test results. Syphilis infection 
was documented for 48 of 235 (20.4%, 1 in 5). Hepatitis 
B infection was documented for 8 of 210 (3.8%, 1 in 25). 
Those who were HIV positive were more likely than those 
who were HIV negative to be infected with syphilis (31.0% 
vs. 15.9%, respectively; odds ratio [OR] 1.88; 95% confi -
dence interval [CI] 1.17–3.03) (Table 1). Similarly, those 
who were HIV positive were more likely than those who 
were HIV negative to be infected with hepatitis B (9.1% vs. 
1.4%, respectively; OR 30.0; 95% CI 7.32–122.7) (Table 
1). Finally, those who were HIV positive were more likely 
than those who were HIV negative to be infected with ei-
ther syphilis or hepatitis B (35.1% vs. 15.1%, respectively; 
OR 1.78; 95% CI 1.11–2.85) (Table 2).
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Conclusions
Our fi ndings demonstrate that HIV-infected sex-
traffi cking victims are more likely to be infected with oth-
er STIs, specifi cally syphilis and hepatitis B, than those 
not infected with HIV. Current evidence of HIV and STI 
co-infection implies a need to strengthen clinical practice 
among providers caring for persons at risk for HIV or oth-
er STIs, particularly high-risk populations such as those 
traffi cked for sexual exploitation or otherwise exposed to 
commercial sex work. Our fi ndings strongly indicate the 
need for syphilis and hepatitis B screening for HIV-in-
fected persons and HIV screening for syphilis- and hepa-
titis B-infected persons. Clinical expertise alone may be 
insuffi cient to guide treatment decisions in the presence of 
undetected co-infection (12,13), resulting in missed case 
detection, incomplete or partial treatment, and suboptimal 
clinical follow-up.
Appropriate diagnosis of co-infection by comprehen-
sive STI and HIV screening is also important for averting 
potential development of pathogen drug resistance, a disas-
trous scenario in a region that is already coping with high 
rates of syphilis, hepatitis B, and HIV infection. From a 
clinical perspective, accurate diagnosis of syphilis, hepa-
titis B, and HIV, alone or in combination, is critical for 
informed selection of medications to be used in combina-
tions or regimens that reduce the likelihood of inciting drug 
resistance for the other pathogens. Furthermore, success of 
STI treatment depends not only on the potency of the an-
tiviral medication but also on the patient’s immunocompe-
tence (14). A decision about when to modify a potentially 
failing or failed STI treatment regimen may thus be better 
informed by knowledge of HIV status.
Current data highlight prior calls for secondary preven-
tion efforts (i.e., prevention of subsequent transmission) for 
this population because migration and repatriation of such 
women and girls has been described as a major factor in the 
spread of HIV and STIs across South Asia (4). Evidence 
from the World Health Organization shows that effective 
treatment of a variety of STIs can reduce HIV transmission 
rates because many STIs are increasing the risk for HIV 
acquisition (15). Therefore, treatment of prevailing STIs 
at the time of repatriation could potentially lessen risk for 
future HIV acquisition and reduce subsequent transmission 
to sex partners. The ability to properly treat and reduce the 
propagation of STIs represents an avenue by which to im-
prove the health of the individual patients as well as poten-
tially reduce rates of HIV in the region.
Finally, these data underscore the need for efforts by 
both government and nongovernment organizations to ex-
pand support for appropriate healthcare services to sex-
traffi cked women and girls and to develop comprehensive 
screening guidelines and treatment programs. Currently, 
most of the few nongovernment organizations serving this 
vulnerable population are unable to provide the quality of 
care indicated by our fi ndings. Such improvements are ur-
gently needed to help reduce the alarmingly high rates of 
HIV and co-occurring STIs among victims of sex traffi ck-
ing and to curb the spread of these co-occurring epidemics 
throughout the region.
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Table 1. Prevalence and likelihood of infection with syphilis or hepatitis B, by HIV serostatus, among sex-trafficked women and girls, 
Nepal
Syphilis (n = 235) HIV status, no. (%)* 
Syphilis positive,  
no. (%)† 
Syphilis negative,  
no. (%)† 
McNemar test 
statistic OR (95% CI)† 
 HIV positive 71 (30.2) 22 (31.0) 49 (69.0) 6.45, p<0.05 1.88 (1.17–3.03) 
 HIV negative 164 (69.8) 26 (15.9) 138 (84.1) Referent
 Total  235 48 (20.4)§ 187(79.6)§ 
Hepatitis B (n = 210) 
Hepatitis B positive, 
no. (%)† 
Hepatitis B negative, 
no. (%)† 
 HIV positive 66 (31.4) 6 (9.1) 60 (90.9) 52.4, p<0.0001 30.0 (7.32–122.73) 
 HIV negative 144 (68.6) 2 (1.4) 142 (98.6) Referent
 Total 210 8 (3.8)‡  202 (96.1)‡ 
*Percentages based on HIV serostatus.  
†OR, odds ratio, CI, confidence interval.  
‡Percentages based on total sample tested for HIV and syphilis or hepatitis B. 
Table 2. Prevalence and likelihood of co-infection with syphilis or hepatitis B based on HIV serostatus (n = 246), among sex-trafficked
women and girls, Nepal 
HIV status 
HIV status, 
no. (%) 
Syphilis and/or hepatitis B 
positive, no. (%)* 
Syphilis and hepatitis B 
negative, no. (%)*
McNemar test 
statistic OR, 95% CI† 
Positive 74 (30.1) 26 (35.1) 48 (64.9) 5.33, p<0.05 1.78 (1.11–2.85) 
Negative 172 (69.9) 27 (15.7) 145 (84.3) Referent
Total 246 53 (21.5)‡ 193 (78.5)‡ 
*Percentages based on HIV serostatus. 
†OR, odds ratio, CI, confidence interval.  
‡Percentages based on total sample tested for HIV, syphilis, or hepatitis B. 
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